Pfizer Covid-19 vaccine on track for regulatory review in October
The companies said the vaccine was well tolerated with mild to moderate fever in fewer than 20% of the participants. (Representational image: Reuters) Pfizer Inc. and BioNTech SE said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, as they released additional data from … Read more